XLS《备案采购申投诉》

"序号","通用名","剂型","规格","包装","生产企业名称","申报企业名称","批准文号","挂网价中标价","目录类型","投诉内容","投诉处理结果" "1","盐酸莫西沙星氯化钠注射液","注射剂","250ml:莫西沙星0.

4g与氯化钠2.0g/袋","1袋/袋","江苏正大丰海制药有限公司","江苏正大丰海制药有限公司","国药准字H20183412","251.60015625","备案采购","投诉:该品种和莫西沙星注射液是同一产品,已有国产产品挂网,该品种不符合备案要求,建议不予挂网,且该品种申请挂网价格不符合方案要求,存在重庆212.6元/袋挂网价.","盐酸莫西沙星氯化钠注射液(250ml:莫西沙星0.4g与氯化钠2.0g/袋)和盐酸莫西沙星注射液(20ml:400mg)仅规格有差别,有效成分完全一样,氯化钠起调节渗透压的作用.专家认为盐酸莫西沙星氯化钠注射液(250ml:莫西沙星0.4g与氯化钠2.0g/袋)非医疗机构临床必需,平台有替代品种,不符合备案采购要求." "2","盐酸莫西沙星氯化钠注射液","注射剂","250ml:莫西沙星0.4g与氯化钠2.0g/袋","1袋/袋","成都正康药业有限公司","成都正康药业有限公司","国药准字H20183366","210","备案采购","投诉:该品种和莫西沙星注射液是同一产品,已有国产产品挂网,该品种不符合备案要求,建议不予挂网.","盐酸莫西沙星氯化钠注射液(250ml:莫西沙星0.4g与氯化钠2.0g/袋)和盐酸莫西沙星注射液(20ml:400mg)仅规格有差别,有效成分完全一样,氯化钠起调节渗透压的作用.专家认为盐酸莫西沙星氯化钠注射液(250ml:莫西沙星0.4g与氯化钠2.0g/袋)非医疗机构临床必需,平台有替代品种,不符合备案采购要求." "3","盐酸莫西沙星氯化钠注射液","注射剂","250ml:莫西沙星0.4g与氯化钠2.0g/袋","1袋/袋","石家庄四药有限公司","石家庄四药有限公司","国药准字H20183411","198","备案采购","投诉:该品种和莫西沙星注射液是同一产品,已有国产产品挂网,该品种不符合备案要求,建议不予挂网.","盐酸莫西沙星氯化钠注射液(250ml:莫西沙星0.4g与氯化钠2.0g/袋)和盐酸莫西沙星注射液(20ml:400mg)仅规格有差别,有效成分完全一样,氯化钠起调节渗透压的作用.专家认为盐酸莫西沙星氯化钠注射液(250ml:莫西沙星0.4g与氯化钠2.0g/袋)非医疗机构临床必需,平台有替代品种,不符合备案采购要求." "4","痘苗病毒致炎兔皮提取物注射液","注射液","3ml:3.6IU","10瓶/瓶","威世药业(如皋)有限公司","威世药业(如皋)有限公司","国药准字S20040022","70","备案采购","投诉:该品种申请挂网价格不符合方案要求,存在内蒙古挂网价31.1元/支以及河南25.73元/支、贵州37.3元/支、福建34.69元/支、山东48元/支、甘肃37.28元/支挂网价.","该品种执行了新的质量标准,产品名称由牛痘疫苗致炎兔皮提取物注射液变更为痘苗病毒致炎兔皮提取物注射液,工艺和成本均已提高,应使用新通用名药品的全国最低挂网价作为我省备案采购的价格,挂网价格70元/支,允许备案挂网." "5","注射用头孢他啶","溶媒结晶粉针剂","1.0g","1瓶/瓶","成都倍特药业有限公司","成都倍特药业有限公司","国药准字H20043426","29.86001953125","备案采购","投诉:

1、国家药监局网站并未查询到该品种增加适应症或特殊用法用量的相关补充批件,该品种并未增加适应症,不符合备案采购要求.